Company Tagline
Discovering and developing first-in-class non-absorbed oral therapeutics to prevent and treat ion-related human diseases
Industry Category
Business Keywords
Company Description
Bond Biosciences is a dynamic biotechnology company dedicated to discovering and developing innovative, first-in-class oral therapeutics. Bond Biosciences focuses on creating non-absorbed treatments designed to prevent and treat ion-related human diseases. With a commitment to addressing unmet medical needs, Bond Biosciences is advancing novel solutions for patient care.
Located at 170 English Landing Dr, Suite 201B, Parkville, Missouri 64152, US, Bond Biosciences is strategically positioned to leverage cutting-edge research and development in the biopharmaceutical sector. Bond Biosciences aims to improve patient outcomes and quality of life through targeted therapeutic interventions.
Bond Biosciences is poised for significant growth and commercial development within the biotechnology landscape. We invite the manager of Bond Biosciences to create a customized and exclusive company showcase and product listing on our platform, to further enhance visibility and market reach.
Key Personnel / Employees
Similar Companies
Other organizations in the same industry
formerly Helomics
BiotechnologyAs a part of Predictive Oncology, our mission is to change the landscape of oncology drug discovery.
Alternative Company Names
This company is also known as